Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

AbbVie Inc (NYSE:ABBV)

92.17
Delayed Data
As of 4:00pm ET
 +1.13 / +1.24%
Today’s Change
55.06
Today|||52-Week Range
92.78
+47.19%
Year-to-Date
ABBV Regular Dividend: ABBV began trading ex-dividend on 10/12/17. A $0.64 dividend will be paid to shareholders of record as of 10/13/17.

Today’s Trading

Previous close91.04
Today’s open91.04
Day’s range90.95 - 92.78
Volume5,280,458
Average volume (3 months)6,001,275
Market cap$145.1B
Dividend yield2.78%
Data as of 4:00pm ET, 10/17/2017

Growth & Valuation

Earnings growth (last year)+15.97%
Earnings growth (this year)+14.71%
Earnings growth (next 5 years)+15.00%
Revenue growth (last year)+12.16%
P/E ratio22.6
Price/Sales3.98
Price/Book31.27

Competitors

 Today’s
change
Today’s
% change
SNYSanofi-0.04-0.08%
CELGCelgene+2.15+1.57%
GSKGlaxoSmithKline-0.03-0.07%
BMYBristol-Myers Squibb+0.53+0.83%
Data as of 4:02pm ET, 10/17/2017

Financials

Next reporting dateOctober 27, 2017
EPS forecast (this quarter)$1.38
Annual revenue (last year)$25.6B
Annual profit (last year)$5.9B
Net profit margin23.10%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Major
Chairman &
Chief Executive Officer
Richard A. Gonzalez
Senior Vice President-
Operations
Azita Saleki-Gerhardt
Corporate headquarters
North Chicago, Illinois

Forecasts